A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy.

Trial Profile

A Non-Interventional, Post-Marketing Surveillance, Phase IV Study to Assess Compliance With Antihypertensive Telmisartan Therapy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2012

At a glance

  • Drugs Telmisartan (Primary)
  • Indications Hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms COAST
  • Sponsors Bayer
  • Most Recent Events

    • 02 Mar 2010 Actual patient number (3300 ) added as reported by ClinicalTrials.gov (NCT00470886).
    • 02 Mar 2010 Actual patient number (3300 ) added as reported by ClinicalTrials.gov (NCT00470886).
    • 02 Mar 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov (NCT00470886).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top